Literature DB >> 10938742

Susceptibility of juvenile and sub-adult Atlantic halibut (Hippoglossus hippoglossus L.) to infection by Vibrio anguillarum and efficacy of protection induced by vaccination.

I R Bricknell1, T J Bowden, D W Verner-Jeffreys, D W Bruno, R J Shields, A E Ellis.   

Abstract

Experimental bath challenge of juvenile and sub-adult Atlantic halibut with Vibrio anguillarum induced severe mortalities of 47 and 80%, respectively. However, animals vaccinated with a commercial V. anguillarum vaccine demonstrated excellent protection against the disease (100% RPS). This study also describes the gross pathology and histological changes associated with this infection. A loss of coordination, haemorrhage at the fin base and splenomegaly were frequent findings. Serum agglutinating activity demonstrated a rise following vaccination, the mean log2 titre rising from 3.8 to 8.4. This was associated with a significant rise in antibody-mediated complement killing ability of immune serum when compared to non-immune serum.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10938742     DOI: 10.1006/fsim.1999.0240

Source DB:  PubMed          Journal:  Fish Shellfish Immunol        ISSN: 1050-4648            Impact factor:   4.581


  2 in total

1.  Comparative genomics profiling of clinical isolates of Aeromonas salmonicida using DNA microarrays.

Authors:  John H E Nash; Wendy A Findlay; Christian C Luebbert; Oksana L Mykytczuk; Simon J Foote; Eduardo N Taboada; Catherine D Carrillo; Jessica M Boyd; Duncan J Colquhoun; Michael E Reith; Laura L Brown
Journal:  BMC Genomics       Date:  2006-03-07       Impact factor: 3.969

2.  Exploring the Effect of Phage Therapy in Preventing Vibrio anguillarum Infections in Cod and Turbot Larvae.

Authors:  Nanna Rørbo; Anita Rønneseth; Panos G Kalatzis; Bastian Barker Rasmussen; Kirsten Engell-Sørensen; Hans Petter Kleppen; Heidrun Inger Wergeland; Lone Gram; Mathias Middelboe
Journal:  Antibiotics (Basel)       Date:  2018-05-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.